|
Purpose
|
A carnitine palmitoyltransferase I (CPT1) inhibitor
|
|
Characteristics
|
R-(+)-Etomoxir is a carnitine palmitoyltransferase I (CPT1) inhibitor which is required for the oxidation of long chain acyl CoA esters. It inhibits β-oxidation in mitochondria and shown to inhibit biosynthesis of cardiolipin from exogenous fatty acid in H9c2 cells. Potential antidiabetic drug.
|
|
Purity
|
≥ 98 % by HPLC
|
|
Chemical Name
|
(R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid, ethyl ester
|
|
Formula
|
C₁₇H₂₃ClO₄
|
|
Permeability
|
Cell-permeable
|
|
Solubility
|
DMSO (>8 mg/ml)
|
